In today's Pharmalittle roundup, we're reading about Congress eyeing a Trump drug pricing plan, questions on a Sarepta drug, ...

Clogged arteries are usually the villain in heart attacks. But they’re not the only suspects, especially in women under 65, ...

I am deeply saddened for the agency I was honored to lead, for colleagues put in harm’s way, and for the quiet heroism of ...

Prominent critics say Sarepta’s Elevidys Duchenne therapy may overstate how much gene it delivers—raising new questions about ...

Downgrading marijuana to Schedule III would have surprisingly little impact on health or research, experts say.

The dearth of appropriate research — and guidance — around medication use in pregnancy disguises concern for the fetus as ...

Experts joined Congressional staff behind closed doors to discuss Trump's most-favored nation drug pricing plan.

Former surgeon general Jerome Adams has a rule for himself: focus on the policy, not the person. But last week, he broke that ...

Federal health officials announced the appointment of five new members to the ACIP, a key CDC advisory panel on vaccine issues.

In today's Pharmalittle roundup, we're reading about FDA targeting Hims & Hers, AstraZeneca halting U.K. investment, and much ...

While leaders of federal health agencies in the U.S. revive decades-settled questions about vaccination, the WHO recently ...

My 12-year-old son died from brain cancer. The defunding of the Pediatric Brain Tumor Consortium will deny treatments to ...